Literature DB >> 9396428

Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67.

R Brandl1, T Richter, K Haug, M G Wilhelm, P C Maurer, W Nathrath.   

Abstract

BACKGROUND: On the basis of contradictory results found in animal experiments and coronary atherectomy tissue, there is an ongoing debate about the significance of cellular proliferation in human atherosclerosis. In the present prospective study, the cell cycle-related antigen Ki-67 was detected for topographic determination of cell turnover in distinct regions of human carotid endarterectomy specimens harvested en bloc by surgical biopsy. METHODS AND
RESULTS: After en bloc resection, serial sections of 26 consecutive carotid lesions were analyzed by histomorphological examination and immunohistochemistry. Thereby, 319 high-power fields were attributed to separate plaque regions defined as follows: distal boundary of the lesion with normal intima, plaque shoulder, core region, and diffuse intimal thickening. Endothelial cells, smooth muscle cells, T cells, and macrophages were identified by immunostaining of factor VIII-related protein, alpha-actin, CD68, and CD45R0. An overall proliferation index of 0.49+/-1.05% was yielded by positive anti-Ki-67 immunolabeling, predominantly in macrophage-rich areas characterized by high cell density (>1000 cells/mm2) as well as in reparative sites in the perimeter of atheroma, intramural thrombosis, plaque hemorrhage, and neovascularization (P<.01). Few or no signs of proliferation activity were found in normal intima, in areas of dense alpha-actin positivity, or adjacent media. As shown by double immunostaining, macrophages and unspecified mesenchymal cells represented the prevailing proliferating cell type.
CONCLUSIONS: Our results suggest that proliferation in advanced human carotid lesions is confined to the intima and focally concentrated in central plaque regions negative for alpha-actin. Furthermore, it apparently occurs primarily as part of inflammatory processes and structural repair predominantly involving macrophages, as well as unspecific mesenchymal cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396428     DOI: 10.1161/01.cir.96.10.3360

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  [Angiology update].

Authors:  C Ranke; H J Trappe
Journal:  Med Klin (Munich)       Date:  1999-05-15

2.  Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

Authors:  W Siess; K J Zangl; M Essler; M Bauer; R Brandl; C Corrinth; R Bittman; G Tigyi; M Aepfelbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood.

Authors:  Lisa J Schober; Anna L Khandoga; Suman Dwivedi; Sandra M Penz; Takayuki Maruyama; Richard Brandl; Wolfgang Siess
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

Review 4.  Apoptosis in the vasculature: mechanisms and functional importance.

Authors:  Z Mallat; A Tedgui
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Up-regulation of a hydrogen peroxide-responsive pre-mRNA binding protein in atherosclerosis and intimal hyperplasia.

Authors:  Mikhail P Panchenko; Nilsa Silva; James R Stone
Journal:  Cardiovasc Pathol       Date:  2008-05-27       Impact factor: 2.185

6.  The early- and late stages in phenotypic modulation of vascular smooth muscle cells: differential roles for lysophosphatidic acid.

Authors:  Huazhang Guo; Natalia Makarova; Yunhui Cheng; Shuyu E; Rui-Rui Ji; Chunxiang Zhang; Patricia Farrar; Gabor Tigyi
Journal:  Biochim Biophys Acta       Date:  2008-06-13

7.  Histological topographical comparisons of atherosclerosis progression in juveniles and young adults.

Authors:  Satoki Homma; Dana A Troxclair; Arthur W Zieske; Gray T Malcom; Jack P Strong
Journal:  Atherosclerosis       Date:  2007-09-14       Impact factor: 5.162

8.  GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques.

Authors:  Anna L Khandoga; Dharmendra Pandey; Ulrich Welsch; Richard Brandl; Wolfgang Siess
Journal:  Cardiovasc Res       Date:  2010-11-23       Impact factor: 10.787

9.  Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque.

Authors:  Suman Dwivedi; Dharmendra Pandey; Anna L Khandoga; Richard Brandl; Wolfgang Siess
Journal:  J Transl Med       Date:  2010-12-06       Impact factor: 5.531

10.  Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.

Authors:  Janina Jamasbi; Remco T A Megens; Mariaelvy Bianchini; Götz Münch; Martin Ungerer; Alexander Faussner; Shachar Sherman; Adam Walker; Pankaj Goyal; Stephanie Jung; Richard Brandl; Christian Weber; Reinhard Lorenz; Richard Farndale; Natalie Elia; Wolfgang Siess
Journal:  J Am Coll Cardiol       Date:  2015-06-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.